161 results on '"Narducci, Maria Grazia"'
Search Results
2. Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far
3. Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma
4. Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance
5. TCL1 Participates in Early Embryonic Development and Is Overexpressed in Human Seminomas
6. Deregulated Expression of TCL1 Causes T Cell Leukemia in Mice
7. Data from CXCL13 Is Highly Produced by Sézary Cells and Enhances Their Migratory Ability via a Synergistic Mechanism Involving CCL19 and CCL21 Chemokines
8. Supplementary Table 2 from Identification of Key Regions and Genes Important in the Pathogenesis of Sézary Syndrome by Combining Genomic and Expression Microarrays
9. Supplementary Table 1 from Identification of Key Regions and Genes Important in the Pathogenesis of Sézary Syndrome by Combining Genomic and Expression Microarrays
10. Supplementary Figure 1 and Table 1 from CXCL13 Is Highly Produced by Sézary Cells and Enhances Their Migratory Ability via a Synergistic Mechanism Involving CCL19 and CCL21 Chemokines
11. Data from Identification of Key Regions and Genes Important in the Pathogenesis of Sézary Syndrome by Combining Genomic and Expression Microarrays
12. Supplementary Figure 1 from Identification of Key Regions and Genes Important in the Pathogenesis of Sézary Syndrome by Combining Genomic and Expression Microarrays
13. Supplementary Table 3 from Identification of Key Regions and Genes Important in the Pathogenesis of Sézary Syndrome by Combining Genomic and Expression Microarrays
14. Supplementary Table 4 from Identification of Key Regions and Genes Important in the Pathogenesis of Sézary Syndrome by Combining Genomic and Expression Microarrays
15. Supplementary Figure 2 from Identification of Key Regions and Genes Important in the Pathogenesis of Sézary Syndrome by Combining Genomic and Expression Microarrays
16. Genome Data Link from Identification of Key Regions and Genes Important in the Pathogenesis of Sézary Syndrome by Combining Genomic and Expression Microarrays
17. Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome
18. Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy
19. Comprehensive analysis of PTEN status in Sézary syndrome
20. Role of Neutrophil-to-Lymphocyte Ratio (NLR) in Patients with Mycosis Fungoides.
21. Single TCR-Vβ2 evaluation discloses the circulating T cell clone in Sezary syndrome: one family fits all!
22. Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome
23. Continuous low‐dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study
24. IgE reactivity and survival probabilities in Sézary syndrome
25. Identification of the TCL1 Gene Involved in T-Cell Malignancies
26. Chromosome Walking on the TCL1 Locus Involved in T-Cell Neoplasia
27. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV
28. From single-cell signature to prognostic factors: the case of Sézary syndrome
29. Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab
30. Impaired T- and B-cell development in Tcl1-deficient mice
31. The murine Tcl1 oncogene: embryonic and lymphoid cell expression
32. T Cell Receptor-Vβ Analysis Identifies a Dominant CD60+ CD26− CD49d− T Cell Clone in the Peripheral Blood of Sézary Syndrome Patients
33. Acquired Chromosome 11q Deletion Involving the Ataxia Teleangiectasia Locus in B-Cell Non-Hodgkin’s Lymphoma: Correlation With Clinicobiologic Features
34. Skewed Expression of Activation, Differentiation and Homing-Related Antigens in Circulating Cells from Patients with Cutaneous T Cell Lymphoma Associated with CD7− T Helper Lymphocytes Expansion
35. Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos
36. Abstract 3912: The PI3K/mTOR dual inhibitor PF-04691502 shows antitumor activity in Sezary cells and in a xenograft mouse model
37. Loss of β-arrestin-2 gene and possible functional consequences on Sezary Syndrome
38. Sézary Syndrome, recent biomarkers and new drugs
39. Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos.
40. Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance
41. T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1
42. Abstract 761: The role of PI3 kinase pathway in the the skin of Sezary syndrome
43. Abstract 936: Skin microenvironment enhances proliferation index and activates mTORC 1 signaling in sezary syndrome
44. Abstract 3974: A preclinical study for miR181b as therapeutic in Eu-TCL1FL-tg mouse model for CLL
45. Gistic Evaluation in Sezary Syndrome
46. Abstract 4178: Tcl1 enhances keratinocytes’ survival/proliferation by promoting erk and jnk/sap phosphorylation at the expense of p38 and by controlling c-fos expression through miR-29b and miR-181a-1
47. Specific IgE toward Allergenic Molecules Is a New Prognostic Marker in Patients with Sézary Syndrome
48. Abstract 150: Regulation of TGFB receptor by miR21 in Sezary syndrome
49. Abstract 1736: Skewed usage of TCRVbeta repertoire and predictive role of CD60 and CD49d expression in the survival rate of patients with Sézàry Syndrome
50. Combined High Resolution Genomic and Expression Profiles Microarray Analysis in Sezary Syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.